The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

Jurgen Eckel, TANAKA Hideho, ISHII ShinichiLisen Liu, Hideho Tanaka

    Research output: Contribution to journalArticle

    Original languageEnglish
    JournalDefault journal
    Publication statusPublished - 1998 Jun 13

    Cite this

    The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis. / Eckel, Jurgen; Hideho, TANAKA; Liu, ISHII ShinichiLisen; Tanaka, Hideho.

    In: Default journal, 13.06.1998.

    Research output: Contribution to journalArticle

    @article{75d8953725b6409ca1b786672490dd8a,
    title = "The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis",
    author = "Jurgen Eckel and TANAKA Hideho and Liu, {ISHII ShinichiLisen} and Hideho Tanaka",
    year = "1998",
    month = "6",
    day = "13",
    language = "English",
    journal = "Default journal",

    }

    TY - JOUR

    T1 - The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

    AU - Eckel, Jurgen

    AU - Hideho, TANAKA

    AU - Liu, ISHII ShinichiLisen

    AU - Tanaka, Hideho

    PY - 1998/6/13

    Y1 - 1998/6/13

    M3 - Article

    JO - Default journal

    JF - Default journal

    ER -